Bridger Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$62.7M |
| 2 |
Humana
HUM
|
+$56.8M |
| 3 |
SGI
Somnigroup International
SGI
|
+$45.4M |
| 4 |
Morgan Stanley
MS
|
+$40.4M |
| 5 |
Adient
ADNT
|
+$34.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$56.8M |
| 2 |
AET
Aetna Inc
AET
|
+$51.3M |
| 3 |
Merck
MRK
|
+$50.9M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$38.2M |
| 5 |
Incyte
INCY
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.58% |
| 2 | Consumer Discretionary | 11.84% |
| 3 | Communication Services | 7.08% |
| 4 | Industrials | 5.75% |
| 5 | Consumer Staples | 5.35% |
Similar funds
Bridger Management's Q1 2017 Portfolio in Review
As of Q1 2017, Bridger Management held 42 positions worth $1.75B, up 22% from $1.44B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Bridger Management deployed $99.9M of net new capital in Q1 2017, opening 6 new positions and adding to 14 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,838,440 shares worth $59M.
By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 51% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Incyte, an estimated $29.6M trimmed.
- Bridger Management's largest Q1 2017 buy was Teva Pharmaceuticals: 1,838,440 shares worth $59M.
- Bridger Management added most to Shire pic in Q1 2017, an estimated $28.6M increase.
- Bridger Management's biggest Q1 2017 reduction was Incyte, cutting an estimated $29.6M.
- Bridger Management fully exited UnitedHealth in Q1 2017, selling an estimated $56.8M.
- Bridger Management's ten largest holdings make up 44% of its $1.75B portfolio in Q1 2017.
- Bridger Management opened 6 new positions and closed 5 in Q1 2017.
- Bridger Management's portfolio value rose 22% quarter-over-quarter to $1.75B.
Based on Bridger Management's 13F filing for Q1 2017, filed 15 May 2017.